Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record now presents details of the CX-188 Phase 1 trial, including its study design, eligibility criteria, treatment arms, outcomes, locations, and record dates, instead of an error page.SummaryDifference34%

- Check15 days agoChange DetectedThe footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2; the study record remains unavailable behind a 403 Forbidden page.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The clinical trial record itself still displays a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error when attempting to view the study record, blocking access to the study content on ClinicalTrials.gov.SummaryDifference15%

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.